Moderna

Yahoo Finance • last month

Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. On Thursday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Moderna Inc (NASDAQ:MRNA). This decision comes am... Full story

Yahoo Finance • 2 months ago

Jim Cramer Reports That Moderna, Inc. (MRNA) Was ‘Down Nearly 44% In The Third Quarter’

We recently compiled a list of the Jim Cramer's List of Stocks that Finished Dead Last.In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other Jim Cramer stocks that finished dead last. I... Full story

Yahoo Finance • 2 months ago

Is Moderna, Inc. (MRNA) the Worst Performing Stock to Buy on the Dip?

We recently compiled a list of 10 Worst Performing Stocks to Buy on the Dip. In this article, we will look at where Moderna, Inc. (NASDAQ:MRNA) ranks among the worst performing stocks to buy on the dip. Capital markets demonstrated increa... Full story

Yahoo Finance • 2 months ago

Top 3 Health Care Stocks That May Explode This Month

Top 3 Health Care Stocks That May Explode This Month Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. The most oversold stocks in the health care sector present an opportunity to buy in... Full story

Yahoo Finance • 2 months ago

Funds set to benefit from falling interest rates

Major central banks have started lowering interest rates, with more cuts on the cards before the year is out, and investment experts say it's important to position your portfolios accordingly. The US Federal Reserve announced its first ra... Full story

Yahoo Finance • 3 months ago

Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada

Milestone marks a significant step toward producing mRNA vaccines in Canada by 2025 CAMBRIDGE, MA / ACCESSWIRE / September 9, 2024 / Moderna, Inc. (Nasdaq:MRNA) today announced that its manufacturing facility in Laval, Quebec, has been gr... Full story

Yahoo Finance • 3 months ago

Street Calls of the Week: Moderna upgraded, downgrade for Hershey

Investing.com -- Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week. InvestingPro subscribers always get first dibs on market-moving AI analyst comments. Upgrade today! Petrobras What happened? On Mo... Full story

Yahoo Finance • 3 months ago

Pfizer. Inc. (PFE): One of the Best Affordable Stocks Under $40 According to Short Sellers

We recently compiled a list of the 10 Best Affordable Stocks Under $40 According to Short Sellers.In this article, we are going to take a look at where Pfizer. Inc. (NYSE:PFE) stands against the other affordable stocks under $40. Several... Full story

Yahoo Finance • 3 months ago

US clears updated COVID shots from Novavax, adding a 3rd fall vaccine option

U.S. regulators have cleared a third updated COVID-19 vaccine for this fall, shots made by Novavax Inc. Already, Pfizer and Moderna are shipping shots modified to better match more recent strains of the ever-evolving coronavirus. Those do... Full story

Yahoo Finance • 3 months ago

Moderna, Inc. (MRNA): Among The Best Medical AI Companies

We recently compiled a list of the 10 Best Medical AI Companies.In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other medical AI companies. The Need for AI in Healthcare Generally, whe... Full story

Yahoo Finance • 3 months ago

Moderna Wins European Commission Approval for Respiratory Syncytial Virus Vaccine

Moderna Wins European Commission Approval for Respiratory Syncytial Virus Vaccine... Full story

Yahoo Finance • 3 months ago

Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)

CAMBRIDGE, MA / ACCESSWIRE / August 23, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for mRESVIA® (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, t... Full story

Yahoo Finance • 3 months ago

Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1

CAMBRIDGE, MA / ACCESSWIRE / August 23, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for a partial change application for an updated formul... Full story

Yahoo Finance • 3 months ago

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.43%

Investing.com – U.S. stocks were lower after the close on Thursday, as losses in the Technology, Consumer Goods and Consumer Services sectors led shares lower. At the close in NYSE, the Dow Jones Industrial Average lost 0.43%, while the S... Full story

Yahoo Finance • 3 months ago

Moderna to Host Investor Event - R&D Day and Business Updates

CAMBRIDGE, MA / ACCESSWIRE / August 22, 2024 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - R&D Day and Business Updates at 9:00 a.m. ET on Thursday, September 12, 2024. The event will include present... Full story

Yahoo Finance • 3 months ago

Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?

Pfizer(NYSE: PFE) and BioNTech(NASDAQ: BNTX) recently fell behind in their race with Moderna(NASDAQ: MRNA) to develop new combination shots that could be worth billions in annual sales. Top-line results from an experimental vaccination to... Full story

Yahoo Finance • 3 months ago

Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows

Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows Researchers from the Universities of Cambridge, Bristol, and Edinburgh hav... Full story

Yahoo Finance • 4 months ago

BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products

BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products Monday, BioNTech SE (NASDAQ:BNTX) reported deeper losses in the second quarter of 2024, with an EPS loss of... Full story

Yahoo Finance • 4 months ago

Baillie Gifford's Strategic Moves in Q2 2024: A Closer Look at NVIDIA Corp's Impact

Insight into Baillie Gifford (Trades, Portfolio)'s Latest 13F Filings and Portfolio Adjustments Warning! GuruFocus has detected 3 Warning Signs with NVDA. Baillie Gifford (Trades, Portfolio), a century-old investment management firm, rec... Full story

Yahoo Finance • 4 months ago

REIT Earnings Off To A Blazing Start Beating Analyst Estimates

REIT Earnings Off To A Blazing Start Beating Analyst Estimates Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. The second quarter earnings season has just begun, and thus far, a half-d... Full story